EN DE
STOCK COMPARISON

CSL vs Trane Technologies: Fair Value & Quality

Both stocks run through our valuation models. Here is how CSL (CSL) and Trane Technologies (TT) compare, as of Aug 8, 2026.

As of Aug 8, 2026, Fair Value Calculator sees CSL as the less overvalued of the two: CSL trades at A$132 versus a fair value of A$107 (-19%), while Trane Technologies trades at $479 versus $212 (-56%).
CSL
CSL.AU · AUD · Health Care
-19%
upside to fair value
overvalued
PriceA$132
Fair ValueA$107
Quality56/100
Trane Technologies
TT · USD · Industrials
-56%
upside to fair value
overvalued
Price$479
Fair Value$212
Quality69/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

CSLTrane Technologies
Valuation
13.8×P/E (TTM)35.8×
2.71×P/S (TTM)4.81×
2.16×P/B12.08×
10.1×EV/EBITDA25.1×
1.82×PEG2.00×
2.4%Dividend yield0.8%
A$2.92Dividend per share$3.87
Profitability
9%Net margin13%
32%Operating margin16%
7%Return on equity37%
7%Return on assets11%
Growth
-2%Revenue growth (YoY)6%
13.7%Avg. growth/yr (3Y)10.1%
10.4%Avg. growth/yr (5Y)11.4%
Balance & size
0.47×Debt / equity0.46×
$42BMarket cap$104B
mixedGrowth qualityhealthy

CSL leads: 8 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

CSLof which business quality 64 · market factors 33 Trane Technologiesof which business quality 71 · market factors 56
ProfitabilityMargins and returns on capital today
50
76
Quality GrowthAre margins and returns improving?
51
52
CashflowEarnings quality: real cash, not paper profit
65
61
Fin. StrengthBalance sheet, leverage, solvency risk
62
71
InvestmentDisciplined investing over empire-building
92
70
Low VolatilityCalm price path (market factor)
69
58
MomentumPrice trend over the last 3–12 months (market factor)
21
50
52W MomentumDistance to the 52-week high (market factor)
12
64
Net IssuanceBuybacks instead of dilution
75
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

CSL

DCF ModelsA$117
Earnings-BasedA$79.73
Dividend DiscountA$52.68
MultiplesA$94.99
Asset-BasedA$27.05
Growth DCFA$99.62
Economic ProfitA$46.85
Growth EarningsA$120

23 of 26 models see the stock below the current price.

Trane Technologies

DCF Models$222
Earnings-Based$112
Dividend Discount$63.35
Multiples$235
Asset-Based$26.07
Growth DCF$212
Economic Profit$153
Growth Earnings$225

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

CSL
Bear A$65.70Fair Value A$107Bull A$165
A$132 = current price (white tick)
Trane Technologies
Bear $136Fair Value $212Bull $306
$479 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

CSL · Health Care

Quality score56 · above median
Fair value upside-19% · above median

Trane Technologies · Industrials

Quality score69 · Top 25%
Fair value upside-56% · bottom 25%

Bottom line

As of Aug 8, 2026, Fair Value Calculator sees CSL as the less overvalued of the two: CSL trades at A$132 versus a fair value of A$107 (-19%), while Trane Technologies trades at $479 versus $212 (-56%).

Trane Technologies has the higher quality score (69/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.